Anavex Life Sciences Corp. (AVXL) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Anavex Life Sciences Corp., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -16.37x | -11.03x | -11.00x | -16.54x | -33.05x | -10.08x |
| P/B Ratio | 8.00x | 3.94x | 3.68x | 5.57x | 8.31x | 9.72x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 11.60x | 8.86x | 12.32x | 14.95x | 14.97x | 4.73x |
| Quick Ratio | 11.60x | 8.86x | 12.32x | 14.95x | 14.97x | 4.73x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..